Filing Details
- Accession Number:
- 0001415889-24-007242
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-07 21:40:13
- Reporting Period:
- 2024-02-29
- Accepted Time:
- 2024-03-07 21:40:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2010135 | John Fesko | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | President, Chief Bus. Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-02-29 | 3,607 | $0.00 | 114,501 | No | 4 | A | Direct | |
Common Stock | Disposition | 2024-03-05 | 15 | $87.37 | 114,486 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-03-05 | 1,823 | $88.37 | 112,663 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- On June 10, 2022, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 14,429 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 29, 2024, the achievement of milestones for the vesting of RSUs covering 3,607 shares of Common Stock was certified.
- Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.